Generalized Nonlinear Models for Pharmacokinetic Data
Generalized Nonlinear Models for Pharmacokinetic Data
Summary. Phase I trials to study the pharmacokinetic properties of a new drug generally involve a restricted number of healthy volunteers. Because of the nature of the group involved in such studies, the appropriate distributional assumptions are not always obvious. These model assumptions include the actual distribution but also the …